GenapSys

Sigma-Aldrich has been developing reagents for the Genius platform for about a year.

This article was originally published February 17.

NEW YORK (GenomeWeb News) –GenapSys said today that it has raised $37 million in a Series B financing round to support commercialization of its next-generation sequencing platform.

NEW YORK (GenomeWeb News) – DNA sequencing technologies startup GenapSys has raised $8.5 million of a target goal of $13.6 million, the company disclosed in a document recently filed with the US Securities and Exchange Commission.

Informatics startup Syapse said this week that it has raised $3 million in Series A venture capital funding to support continued development of software for use in next-generation sequencing-based diagnostics.

People In The News

NEW YORK (GenomeWeb News) – Agilent Technologies said this week that it has appointed Ron Nersesian to be company president as well as chief operating officer, effective immediately.

This article has been updated with additional information from GenapSys.

Genapsys has expanded its management team and scientific advisory board.

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute said today that it has pumped $19 million into new research and development projects that seek to bring down the costs of DNA sequencing.

By Julia Karow
GenapSys of Menlo Park, Calif., is developing a DNA sequencing instrument that will be based on label-free nanosensor array technology.

Pages

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.